Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RMJH-111b in Essential Hypertension
NCT02822222Phase 2Completed
- Sponsor
- RMJ Holding
- Start
- Jun 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RMJH-111b in essential hypertension, sponsored by RMJ Holding. Started Jun 2016; status: completed.
02
Drugs
RMJH-111b
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02822222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02822222.